Corcept Therapeutics
Clinical trials sponsored by Corcept Therapeutics, explained in plain language.
-
New hope for hard-to-treat ovarian cancer: drug combo shows promise in trial
Disease control CompletedThis study tested a new drug, relacorilant, combined with a standard chemotherapy (nab-paclitaxel) in 178 women with ovarian, fallopian tube, or peritoneal cancer that came back and no longer responds to platinum-based chemo. The goal was to see if the combination helps keep the …
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New drug shows promise for cortisol disorder in phase 3 trial
Disease control CompletedThis study tested a drug called relacorilant in 137 people with high cortisol levels due to non-cancerous adrenal gland growths. The goal was to see if the drug could improve blood pressure and blood sugar control. Participants received either the drug or a placebo, and researche…
Phase: PHASE3 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
Hidden hormone culprit found in many tough blood pressure cases
Knowledge-focused CompletedThis study looked at over 1,100 adults in the US whose high blood pressure stays high despite taking multiple medications. Researchers checked how many also have a hormone condition called endogenous hypercortisolism (too much cortisol). Participants provided blood and urine samp…
Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC
-
Healthy volunteers help test new drug formulations
Knowledge-focused CompletedThis study looked at how well two different tablet forms of the drug miricorilant are absorbed by the body. It involved 18 healthy adults who took the drug in different forms and had their blood levels measured. The goal was to compare the formulations, not to treat any disease.
Phase: PHASE1 • Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC